Cabotegravir
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 886 publications
Well-being in people with HIV after one year of long-acting cabotegravir and rilpivirine.
Journal: AIDS care
Published: September 07, 2026
Progress toward longer-acting antiretroviral regimens for adult HIV treatment.
Journal: Expert review of clinical pharmacology
Published: August 26, 2026
Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa.
Journal: AIDS research and human retroviruses
Published: August 25, 2026
Differential pharmacokinetic decay of long-acting cabotegravir and rilpivirine after missed injections: a case series.
Journal: The Journal of antimicrobial chemotherapy
Published: August 11, 2026
Provider Perspectives on the Delivery of Long-Acting PrEP for HIV Prevention to Men Who Have Sex with Men and Who Use Methamphetamine.
Journal: AIDS patient care and STDs
Published: August 05, 2026
Analysis of a clinical pathway for the use of long-acting injectable antiretroviral therapy in adherence challenged people living with HIV.
Journal: International journal of STD & AIDS
Published: July 24, 2026
Health Care Providers' Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey.
Journal: Journal of the International Association of Providers of AIDS Care
Published: July 22, 2026
Selection of Mutations in HIV-1 Nucleocapsid and Integrase in Individuals Living with HIV Experiencing Virologic Failure After Initiating or Switching to Tenofovir-Lamivudine-Dolutegravir.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years.
Journal: JAMA network open
Published: June 26, 2026
Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.
Journal: International journal of STD & AIDS
Published: June 17, 2026
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men: Insights from the PILLAR Trial Through 12 Months.
Journal: AIDS and behavior
Published: June 16, 2026
Long-acting cabotegravir and rilpivirine in people with HIV receiving chronic anticoagulation: A real-world case series.
Journal: British journal of clinical pharmacology
Published: June 11, 2026
Last Updated: 09/26/2026